Aliva Biopharmaceutical Inc entered the industry of Medical Research in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541720, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Larry Couture by calling No number given during business hours. You can also write to the business’ Single Location at 11 West Del Mar Boulevard # 202, Pasadena, California CA 91105. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Aliva Biopharmaceutical Inc |
Representative: | Larry Couture |
Place of Business: | 11 West Del Mar Boulevard # 202, Pasadena, CA 91105 |
Contact Number: | No number given |
Type of Service: | Medical Research |
SIC Number: | 8733 |
NAICS Number: | 541720 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2005 |
Income/Year: | $50.000 to $99.999 |
Laborers: | 1 to 4 |
Share This Company: |
Aliva Biopharmaceutical Inc is a company operating from Los Angeles, California providing professional Medical Research and relevant B2B variables. It was founded in 2005 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 541720 as Medical Research.
With a current employee count of 1 to 4, Aliva Biopharmaceutical Inc has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Larry Couture at No number given for related queries, or to locate its Single Location using the coordinates 34.140867,-118.151005.
The Single Location can also be found at the street address 11 West Del Mar Boulevard # 202 in Pasadena, California 91105 and can be engaged online through the company website at , the company Twitter , and Facebook page .